Sector IntelligenceLugano

VALUATION DIAGNOSTIC
Logistics (Pharma / Cold Chain)

Specific market analysis for Logistics (Pharma / Cold Chain) companies based in Lugano.

Pro-Forma Valuation

Market demand in Lugano for Logistics (Pharma / Cold Chain) assets remains strong.

KEY DRIVER

"GDP compliance, high cost of failure for clients."

Local Multiples (Est.)

5.0 - 7.0x Statutory

Valuation Impact by Size (DACH 2025)

Size BucketMultiple RangeImpact
Micro (< CHF 1M EBITDA)3.0x - 4.1x-33.3%
Small (CHF 1M - 2M EBITDA)4.2x - 5.6x-6.7%
Transition (CHF 2M - 5M EBITDA)5.1x - 6.9x+11.1%
Lower Mid-Market (CHF 5M - 10M EBITDA)7.0x - 9.4x+33.3%
Mid-Market (> CHF 10M EBITDA)8.8x - 11.9x+66.7%

Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 6x

Logistics (Pharma / Cold Chain) Market in Lugano

Lugano — known for a robust financial sector — represents a significant market for Logistics (Pharma / Cold Chain) companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.

Current EBITDA multiples for Logistics (Pharma / Cold Chain) businesses range from 5.0 - 7.0x (statutory) to 6.0 - 9.0x (deal), reflecting a moderate arbitrage opportunity. The sector trend is rising, driven by: GDP compliance, high cost of failure for clients. This positions Lugano as a notable market within the broader Services & Logistics sector.

View Complete Logistics (Pharma / Cold Chain) National Overview →

Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.

Market Pulse

Logistics (Pharma / Cold Chain) in Lugano — stay ahead

Weekly Swiss M&A deals, valuation multiples, and succession signals across Switzerland — free, every Friday.

Free weekly newsletter. Unsubscribe anytime.